JSM 2013 Home
Online Program Home
My Program

Abstract Details

Activity Number: 226
Type: Topic Contributed
Date/Time: Monday, August 5, 2013 : 2:00 PM to 3:50 PM
Sponsor: Biometrics Section
Abstract - #309545
Title: FDA and Innovative Designs: Case Study of a Missed Opportunity
Author(s): Andre Rogatko*+ and Galen Cook-Wiens and Mourad Tighiouart
Companies: Samuel Oschin Comprehensive Cancer Institute At Cedars-Sinai Medical Center and Cedars Sinai Medical Center and Cedars Sinai Medical Center
Keywords: dose finding cancer ; EWOC ; FDA ; accelerated titration ; escalation with overdose control ; phase I trials

The standard 3+3 or "modified Fibonacci" up-and-down (MF-UD) method of dose escalation is by far the most used design in dose-finding cancer early trials. MF-UD was the state-of-the-art in 1971 when it was first used in cancer clinical studies. Since then, over one hundred methodological papers proposing or evaluating dose escalation designs have been published and MF-UD has always shown inferior performance when compared with its competitors regarding maximizing number of patients treated at optimal doses and minimizing number of patients under or overdosed. A consequence of using less effective designs is that more patients are treated with doses outside the therapeutic window. We present a case study where the FDA rejected the proposal to use Escalation with Overdose Control (EWOC), an established dose-finding method which has been extensively used in FDA-approved first in human trials and imposed a suboptimal design, a variation of the MF-UD, known as accelerated titration (AT) design. We show through extensive simulation studies that the AT design has poor operating characteristics relative to two versions of EWOC under several scenarios.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2013 program

2013 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

ASA Meetings Department  •  732 North Washington Street, Alexandria, VA 22314  •  (703) 684-1221  •  meetings@amstat.org
Copyright © American Statistical Association.